GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
HealthCare Global Enterprises Ltd

HealthCare Global Q2 FY27 Revenue up 16% YoY to INR 7,318 Mn; Adjusted EBITDA 17% up

RESULTS ▲ Positive Development LOW RISK
📅 Filed on BSE: 05 Nov 2026, 08:48 PM IST  ·  BSE ID: 338f47a6-817a-4402-aa05-d568005faf3d
View Original BSE Filing (PDF)
💡
In Simple Terms
HealthCare Global reported a 16% rise in quarterly revenue to INR 7,318 million, driven by more patients and higher per-patient income.
🤖 AI Summary
  • HealthCare Global's Q2 FY27 consolidated revenue from operations increased 15.8% YoY to INR 7,318 Mn.
  • Adjusted EBITDA grew 17.2% YoY to INR 1,425 Mn in Q2 FY27, with a margin of 19.7%.
  • Patient volumes rose by 9% YoY and average revenue per patient (ARPP) by 7% in Q2 FY27.
  • Adjusted Profit after Tax was INR 192 Mn for Q2 FY27, reflecting a -9.3% YoY change.
  • International business revenue increased by approximately 54% YoY to INR 302 Mn in Q2 FY27.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Revenue from Operations (Q2 FY27)
7,318 Rs. Mn.
15.8%
Adjusted EBITDA (Q2 FY27)
1,425 Rs. Mn.
17.2%
Adjusted EBITDA Margin (Q2 FY27)
19.7 %
+51 bps
PBT before extraordinary items (Q2 FY27)
301 Rs. Mn.
48.1%
Adjusted Profit after Tax (Q2 FY27)
192 Rs. Mn.
-9.3%
International business revenue (Q2 FY27)
302 Rs. Mn.
54%
🏢 How This Affects the Company
📈
Business Impact
The company's focus on high-complexity oncology treatments and expanding non-institutional business contributed to improved revenue mix and 7% growth in average revenue per patient (ARPP). Increased patient volumes and international business revenue support growth across its cancer hospital network.
💰
Financial Impact
Adjusted EBITDA margin improved by 51 basis points to 19.7% in Q2 FY27, reflecting operational efficiencies. Adjusted Profit after Tax saw a -9.3% YoY change, primarily due to a favorable one-time deferred tax adjustment in the prior year's comparable quarter.
⚙️
Operational Impact
Capacity expansion continued with 25 new operational beds added in Q2 FY27 across Kenya, Kolkata, and Nagpur. New technologies, such as MR-LINAC, and advanced cancer therapies like CAR-T cell therapy, were deployed to enhance treatment capabilities.
⚠️
Risk Impact
The adjusted PAT YoY decline reflects a one-time deferred tax adjustment in Q2 FY26. Future quarters will clarify if adjusted PAT growth aligns with revenue and EBITDA trends without such non-recurring items.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders based on this financial results filing.
👤
Who Is Affected
Shareholders are affected by the company's financial performance, with Q2 FY27 revenue up 15.8% and Adjusted EBITDA up 17.2%. The Adjusted PAT of INR 192 Mn is lower YoY due to specific prior-period tax adjustments.
🔍
Management Signal
Management signals a commitment to advancing oncology care, strengthening research capabilities, expanding network access, and improving asset utilization and productivity.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Q3 FY27 financial results — check for sustained revenue and EBITDA growth rates.
Update on North Bangalore unit performance and loss reduction in subsequent quarters.
Announcements regarding further capacity expansions or technology deployments.
LOW RISK Q2 FY27 Adjusted PAT decline is attributed to a prior one-time tax adjustment, not operational weakness.
💡 Investor Takeaway
HealthCare Global reported Q2 FY27 consolidated revenue of INR 7,318 Mn, up 15.8% YoY. Adjusted EBITDA increased 17.2% to INR 1,425 Mn, with margins at 19.7%. Adjusted PAT saw a -9.3% YoY change to INR 192 Mn, mainly due to a prior year one-time tax adjustment.
⚖️ Strengths & Concerns

✅ Positives

  • Revenue from Operations grew 15.8% YoY to INR 7,318 Mn in Q2 FY27, indicating sustained business momentum.
  • Adjusted EBITDA increased 17.2% YoY to INR 1,425 Mn, with margin improving to 19.7% in Q2 FY27.

⚠️ Concerns

  • Adjusted Profit after Tax declined -9.3% YoY to INR 192 Mn in Q2 FY27, primarily due to a prior year one-time tax adjustment.
  • The North Bangalore unit incurred a loss of INR 61 Mn in Q2 FY27, impacting overall adjusted EBITDA figures.
📅 Company Track Record
HealthCare Global's Q1 FY27 revenue grew to INR 6,782 Mn with Adjusted PAT up 190% YoY to INR 138 Million. The company has consistently reported growth in revenue and Adjusted EBITDA in recent quarters, indicating a positive trend in its core cancer care business.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was HealthCare Global's consolidated revenue in Q2 FY27?
HealthCare Global reported consolidated revenue from operations of INR 7,318 Mn in Q2 FY27, representing a 15.8% year-on-year growth.
What was HealthCare Global's Adjusted EBITDA in Q2 FY27?
The company's Adjusted EBITDA for Q2 FY27 was INR 1,425 Mn, an increase of 17.2% year-on-year, with a margin of 19.7%.
How did HealthCare Global's Adjusted Profit after Tax perform in Q2 FY27?
HealthCare Global's Adjusted Profit after Tax was INR 192 Mn in Q2 FY27, a -9.3% year-on-year change, primarily due to a one-time deferred tax adjustment in Q2 FY26.
What was the growth in patient volumes for HealthCare Global in Q2 FY27?
In Q2 FY27, HealthCare Global's patient volumes increased by 9% year-on-year, while average revenue per patient (ARPP) grew by 7%.
What was HealthCare Global's international business revenue in Q2 FY27?
International business revenue for HealthCare Global grew by approximately 54% year-on-year to INR 302 Mn in Q2 FY27.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.